Glucose Transporters
Proteoglycans
Renal Corpuscle
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 8, 2026

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
Published on: November 25, 2017
1The Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. quaggin@mshri.on.ca
A genetic defect in sialic acid biosynthesis causes a new glomerular disease. Supplementing with a sialic acid precursor reversed kidney damage in mice, suggesting a potential therapy for human kidney diseases.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: